Botulinum neurotoxin for treating tics and obsessive compulsive behaviors

Details for Australian Patent Application No. 2011203509 (hide)

Owner Allergan, Inc.

Inventors Ackerman, Alan H.

Agent Davies Collison Cave

Pub. Number AU-A-2011203509

Parent 2004233821

Filing date 11 July 2011

Wipo publication date 28 July 2011

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 27/00 (2006.01) Drugs for disorders of the senses

A61K 38/12 (2006.01) Medicinal preparations containing peptides - Cyclic peptides

Event Publications

28 July 2011 Application Open to Public Inspection

  Published as AU-A-2011203509

28 July 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203510-Information processing device, information processing method, and information processing program

2011203508-Methods of nonspecific target capture of nucleic acids